Global Oral Contraceptive Market Insights, Forecast to 2025

Date: Feb 13 2019
|
QYRESEARCH
|
Number of Pages: 116
|
Alternate Text Alternate Text Alternate Text Alternate Text

The global Oral Contraceptive market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Contraceptive market based on company, product type, end user and key regions.

This report studies the global market size of Oral Contraceptive in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Contraceptive in these regions.
This research report categorizes the global Oral Contraceptive market by top players/brands, region, type and end user. This report also studies the global Oral Contraceptive market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm

Market size by Product
Combination
Progestin Only
Others
Market size by End User
Male
Female

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Oral Contraceptive market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oral Contraceptive market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oral Contraceptive companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oral Contraceptive submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Oral Contraceptive are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Contraceptive market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Study Coverage
    1.1 Oral Contraceptive Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
           1.4.1 Global Oral Contraceptive Market Size Growth Rate by Product
           1.4.2 Combination
           1.4.3 Progestin Only
           1.4.4 Others
    1.5 Market by End User
           1.5.1 Global Oral Contraceptive Market Size Growth Rate by End User
           1.5.2 Male
           1.5.3 Female
    1.6 Study Objectives
    1.7 Years Considered
2 Executive Summary
    2.1 Global Oral Contraceptive Market Size
           2.1.1 Global Oral Contraceptive Revenue 2014-2025
           2.1.2 Global Oral Contraceptive Sales 2014-2025
    2.2 Oral Contraceptive Growth Rate by Regions
           2.2.1 Global Oral Contraceptive Sales by Regions
           2.2.2 Global Oral Contraceptive Revenue by Regions
3 Breakdown Data by Manufacturers
    3.1 Oral Contraceptive Sales by Manufacturers
           3.1.1 Oral Contraceptive Sales by Manufacturers
           3.1.2 Oral Contraceptive Sales Market Share by Manufacturers
           3.1.3 Global Oral Contraceptive Market Concentration Ratio (CR5 and HHI)
    3.2 Oral Contraceptive Revenue by Manufacturers
           3.2.1 Oral Contraceptive Revenue by Manufacturers (2014-2019)
           3.2.2 Oral Contraceptive Revenue Share by Manufacturers (2014-2019)
    3.3 Oral Contraceptive Price by Manufacturers
    3.4 Oral Contraceptive Manufacturing Base Distribution, Product Types
           3.4.1 Oral Contraceptive Manufacturers Manufacturing Base Distribution, Headquarters
           3.4.2 Manufacturers Oral Contraceptive Product Type
           3.4.3 Date of International Manufacturers Enter into Oral Contraceptive Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
    4.1 Global Oral Contraceptive Sales by Product
    4.2 Global Oral Contraceptive Revenue by Product
    4.3 Oral Contraceptive Price by Product
5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Oral Contraceptive Breakdown Data by End User
6 North America
    6.1 North America Oral Contraceptive by Countries
           6.1.1 North America Oral Contraceptive Sales by Countries
           6.1.2 North America Oral Contraceptive Revenue by Countries
           6.1.3 United States
           6.1.4 Canada
           6.1.5 Mexico
    6.2 North America Oral Contraceptive by Product
    6.3 North America Oral Contraceptive by End User
7 Europe
    7.1 Europe Oral Contraceptive by Countries
           7.1.1 Europe Oral Contraceptive Sales by Countries
           7.1.2 Europe Oral Contraceptive Revenue by Countries
           7.1.3 Germany
           7.1.4 France
           7.1.5 UK
           7.1.6 Italy
           7.1.7 Russia
    7.2 Europe Oral Contraceptive by Product
    7.3 Europe Oral Contraceptive by End User
8 Asia Pacific
    8.1 Asia Pacific Oral Contraceptive by Countries
           8.1.1 Asia Pacific Oral Contraceptive Sales by Countries
           8.1.2 Asia Pacific Oral Contraceptive Revenue by Countries
           8.1.3 China
           8.1.4 Japan
           8.1.5 Korea
           8.1.6 India
           8.1.7 Australia
           8.1.8 Indonesia
           8.1.9 Malaysia
           8.1.10 Philippines
           8.1.11 Thailand
           8.1.12 Vietnam
           8.1.13 Singapore
    8.2 Asia Pacific Oral Contraceptive by Product
    8.3 Asia Pacific Oral Contraceptive by End User
9 Central & South America
    9.1 Central & South America Oral Contraceptive by Countries
           9.1.1 Central & South America Oral Contraceptive Sales by Countries
           9.1.2 Central & South America Oral Contraceptive Revenue by Countries
           9.1.3 Brazil
    9.2 Central & South America Oral Contraceptive by Product
    9.3 Central & South America Oral Contraceptive by End User
10 Middle East and Africa
    10.1 Middle East and Africa Oral Contraceptive by Countries
           10.1.1 Middle East and Africa Oral Contraceptive Sales by Countries
           10.1.2 Middle East and Africa Oral Contraceptive Revenue by Countries
           10.1.3 GCC Countries
           10.1.4 Turkey
           10.1.5 Egypt
           10.1.6 South Africa
    10.2 Middle East and Africa Oral Contraceptive by Product
    10.3 Middle East and Africa Oral Contraceptive by End User
11 Company Profiles
    11.1 Pfizer, Inc.
           11.1.1 Pfizer, Inc. Company Details
           11.1.2 Company Business Overview
           11.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2014-2019)
           11.1.4 Pfizer, Inc. Oral Contraceptive Products Offered
           11.1.5 Pfizer, Inc. Recent Development
    11.2 Bayer AG
           11.2.1 Bayer AG Company Details
           11.2.2 Company Business Overview
           11.2.3 Bayer AG Oral Contraceptive Sales, Revenue and Gross Margin (2014-2019)
           11.2.4 Bayer AG Oral Contraceptive Products Offered
           11.2.5 Bayer AG Recent Development
    11.3 Merck & Co., Inc.
           11.3.1 Merck & Co., Inc. Company Details
           11.3.2 Company Business Overview
           11.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2014-2019)
           11.3.4 Merck & Co., Inc. Oral Contraceptive Products Offered
           11.3.5 Merck & Co., Inc. Recent Development
    11.4 Janssen Global Services, LLC
           11.4.1 Janssen Global Services, LLC Company Details
           11.4.2 Company Business Overview
           11.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue and Gross Margin (2014-2019)
           11.4.4 Janssen Global Services, LLC Oral Contraceptive Products Offered
           11.4.5 Janssen Global Services, LLC Recent Development
    11.5 Mankind Pharma Ltd.
           11.5.1 Mankind Pharma Ltd. Company Details
           11.5.2 Company Business Overview
           11.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2014-2019)
           11.5.4 Mankind Pharma Ltd. Oral Contraceptive Products Offered
           11.5.5 Mankind Pharma Ltd. Recent Development
    11.6 Teva Pharmaceutical Industries Ltd
           11.6.1 Teva Pharmaceutical Industries Ltd Company Details
           11.6.2 Company Business Overview
           11.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue and Gross Margin (2014-2019)
           11.6.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Products Offered
           11.6.5 Teva Pharmaceutical Industries Ltd Recent Development
    11.7 Allergan, plc (Actavis)
           11.7.1 Allergan, plc (Actavis) Company Details
           11.7.2 Company Business Overview
           11.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue and Gross Margin (2014-2019)
           11.7.4 Allergan, plc (Actavis) Oral Contraceptive Products Offered
           11.7.5 Allergan, plc (Actavis) Recent Development
    11.8 Piramal Enterprises Ltd.
           11.8.1 Piramal Enterprises Ltd. Company Details
           11.8.2 Company Business Overview
           11.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2014-2019)
           11.8.4 Piramal Enterprises Ltd. Oral Contraceptive Products Offered
           11.8.5 Piramal Enterprises Ltd. Recent Development
    11.9 Beijing Zizhu Pharm
           11.9.1 Beijing Zizhu Pharm Company Details
           11.9.2 Company Business Overview
           11.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue and Gross Margin (2014-2019)
           11.9.4 Beijing Zizhu Pharm Oral Contraceptive Products Offered
           11.9.5 Beijing Zizhu Pharm Recent Development
12 Future Forecast
    12.1 Oral Contraceptive Market Forecast by Regions
           12.1.1 Global Oral Contraceptive Sales Forecast by Regions 2019-2025
           12.1.2 Global Oral Contraceptive Revenue Forecast by Regions 2019-2025
    12.2 Oral Contraceptive Market Forecast by Product
           12.2.1 Global Oral Contraceptive Sales Forecast by Product 2019-2025
           12.2.2 Global Oral Contraceptive Revenue Forecast by Product 2019-2025
    12.3 Oral Contraceptive Market Forecast by End User
    12.4 North America Oral Contraceptive Forecast
    12.5 Europe Oral Contraceptive Forecast
    12.6 Asia Pacific Oral Contraceptive Forecast
    12.7 Central & South America Oral Contraceptive Forecast
    12.8 Middle East and Africa Oral Contraceptive Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Oral Contraceptive Customers
    14.3 Sales Channels Analysis
           14.3.1 Sales Channels
           14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
    16.1 Research Methodology
           16.1.1 Methodology/Research Approach
           16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.